Literature DB >> 17544105

The patient with GORD and chronically recurrent problems.

André J P M Smout1.   

Abstract

Treatment of gastro-oesophageal reflux disease (GORD) by means of gastric acid secretion inhibition usually is successful. When symptoms persist despite adequate treatment, correctness of the diagnosis of GORD should be questioned. Quite often dyspeptic symptoms are erroneously interpreted as GORD symptoms. Other causes of treatment failure are insufficient acid suppression and oesophageal hypersensitivity. In the management of patients with persistent symptoms oesophageal pH and impedance monitoring are useful techniques. These may provide answers to the question whether the symptoms are reflux-related and whether acid secretion is adequately suppressed.

Entities:  

Mesh:

Year:  2007        PMID: 17544105     DOI: 10.1016/j.bpg.2007.01.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  9 in total

Review 1.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

Review 2.  Esophageal testing: What we have so far.

Authors:  Nicola de Bortoli; Irene Martinucci; Lorenzo Bertani; Salvatore Russo; Riccardo Franchi; Manuele Furnari; Salvatore Tolone; Giorgia Bodini; Valeria Bolognesi; Massimo Bellini; Vincenzo Savarino; Santino Marchi; Edoardo Vincenzo Savarino
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

3.  Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.

Authors:  Bart P L Witteman; Jose M Conchillo; Nicolaas F Rinsma; Bark Betzel; Andrea Peeters; Ger H Koek; Laurents P S Stassen; Nicole D Bouvy
Journal:  Am J Gastroenterol       Date:  2015-03-31       Impact factor: 10.864

4.  Endoluminal fundoplication (ELF) for GERD using EsophyX: a 12-month follow-up in a single-center experience.

Authors:  Alessandro Repici; Uberto Fumagalli; Alberto Malesci; Roberta Barbera; Camilla Gambaro; Riccardo Rosati
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452

Review 5.  NERD: an umbrella term including heterogeneous subpopulations.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

6.  The impact of radiotherapy and GERD on in situ lifetime of indwelling voice prostheses.

Authors:  Paolo Boscolo-Rizzo; Carlo Marchiori; Alessandro Gava; Maria Cristina Da Mosto
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-16       Impact factor: 2.503

7.  Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.

Authors:  Guy-Bernard Cadière; Michel Buset; Vinciane Muls; Amin Rajan; Thomas Rösch; Alexander J Eckardt; Joseph Weerts; Boris Bastens; Guido Costamagna; Michele Marchese; Hubert Louis; Fazia Mana; Filip Sermon; Anna K Gawlicka; Michael A Daniel; Jacques Devière
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 8.  Diagnostic yield of ambulatory oesophageal studies on versus off proton pump inhibitors: a systematic review and meta-analysis.

Authors:  Daphne Ang; Qishi Zheng; Luming Shi; Jan Tack
Journal:  United European Gastroenterol J       Date:  2018-04-20       Impact factor: 4.623

Review 9.  Advances in the Diagnosis of GERD Using the Esophageal pH Monitoring, Gastro-Esophageal Impedance-pH Monitoring, And Pitfalls.

Authors:  Mojgan Forootan; Homayoun Zojaji; Mohammad Javad Ehsani; Mohammad Darvishi
Journal:  Open Access Maced J Med Sci       Date:  2018-10-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.